[go: up one dir, main page]

EA200600085A1 - Капсулы флуконазола с улучшенным высвобождением - Google Patents

Капсулы флуконазола с улучшенным высвобождением

Info

Publication number
EA200600085A1
EA200600085A1 EA200600085A EA200600085A EA200600085A1 EA 200600085 A1 EA200600085 A1 EA 200600085A1 EA 200600085 A EA200600085 A EA 200600085A EA 200600085 A EA200600085 A EA 200600085A EA 200600085 A1 EA200600085 A1 EA 200600085A1
Authority
EA
Eurasian Patent Office
Prior art keywords
capsules
fluconazole
particles
active ingredient
flukonazol
Prior art date
Application number
EA200600085A
Other languages
English (en)
Other versions
EA008585B1 (ru
Inventor
Паль Фекете
Юдит Виргула
Эва Фурдига
Магдольна Левентисне Хусар
Имре Клебович
Немеш Каталин Балогне
Original Assignee
Эгиш Дьёдьсердьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьёдьсердьяр Рт. filed Critical Эгиш Дьёдьсердьяр Рт.
Publication of EA200600085A1 publication Critical patent/EA200600085A1/ru
Publication of EA008585B1 publication Critical patent/EA008585B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Цель изобретения - предложить капсулы флуконазола с улучшенным высвобождением активного ингредиента. Растворение in-vitro, также как и всасывание флуконазола in-vivo из капсул по изобретению происходит быстрее и более стабильно, чем у имеющихся в продаже композиций, содержащих флуконазол. Изобретение базируется на том открытии, что грануляция частиц флуконазола с веществом, способным обеспечивать гидрофильную поверхность у этих частиц, например лактозой, приводит к быстрому и постоянному между частицами высвобождению активного ингредиента. Таким образом, капсулы по данному изобретению подходят для обеспечения улучшенного всасывания указанного активного ингредиента.
EA200600085A 2003-07-02 2004-06-30 Капсулы флуконазола с улучшенным высвобождением EA008585B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0302030A HU227142B1 (en) 2003-07-02 2003-07-02 Capsule of improved release containing fluconazole
PCT/HU2004/000071 WO2005002553A2 (en) 2003-07-02 2004-06-30 Fluconazole capsules with improved release

Publications (2)

Publication Number Publication Date
EA200600085A1 true EA200600085A1 (ru) 2006-08-25
EA008585B1 EA008585B1 (ru) 2007-06-29

Family

ID=89981480

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600085A EA008585B1 (ru) 2003-07-02 2004-06-30 Капсулы флуконазола с улучшенным высвобождением

Country Status (10)

Country Link
EP (1) EP1648451A2 (ru)
CN (1) CN1812783A (ru)
BG (1) BG109430A (ru)
CZ (1) CZ200657A3 (ru)
EA (1) EA008585B1 (ru)
HU (1) HU227142B1 (ru)
PL (1) PL380995A1 (ru)
SK (1) SK50132006A3 (ru)
UA (1) UA82532C2 (ru)
WO (1) WO2005002553A2 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
MD3971C2 (ru) * 2009-04-29 2010-06-30 Дмитрий СКУРТУ Стул-тренажер
PT2736495T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente à adulteração proporcionando libertação imediata de fármaco
ES2648129T3 (es) 2011-07-29 2017-12-28 Grünenthal GmbH Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
KR20160031526A (ko) 2013-07-12 2016-03-22 그뤼넨탈 게엠베하 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형
CN105616378A (zh) * 2014-10-31 2016-06-01 康普药业股份有限公司 一种氟康唑胶囊及其制备方法
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CN113230236A (zh) * 2021-04-29 2021-08-10 山东优杰生物科技有限公司 祛除灰指甲草本贴及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6214386B1 (en) * 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
DE60023465T2 (de) * 1999-03-24 2006-07-20 R.P. Scherer Technologies, Inc., Las Vegas Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
RU2201230C1 (ru) * 2001-12-24 2003-03-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство флузол, обладающее противогрибковым действием

Also Published As

Publication number Publication date
UA82532C2 (ru) 2008-04-25
BG109430A (en) 2006-11-30
HU227142B1 (en) 2010-08-30
EA008585B1 (ru) 2007-06-29
CN1812783A (zh) 2006-08-02
WO2005002553A3 (en) 2005-03-24
CZ200657A3 (cs) 2006-04-12
HU0302030D0 (en) 2003-09-29
SK50132006A3 (sk) 2006-05-04
PL380995A1 (pl) 2007-04-16
HUP0302030A2 (hu) 2005-03-29
EP1648451A2 (en) 2006-04-26
WO2005002553A2 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
ATE375142T1 (de) Medizinische aerosolformulierungen
EA200800927A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
EA200901365A1 (ru) Стабилизированная фармацевтическая композиция, содержащая прегабалин
EA200600085A1 (ru) Капсулы флуконазола с улучшенным высвобождением
EA200701816A1 (ru) Продукты, включающие микрокапсулы с быстрым высвобождением
PE20061016A1 (es) Una formulacion solida de dosificacion farmaceutica
AR054511A1 (es) Una composicion que comprende emtricitabina y tenofovir df granuladas en seco
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
BRPI0612901B8 (pt) formulações gastrorretentivas e processo para preparação das mesmas
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
DK1776349T3 (da) 2-amino-puinazolin derivater anvendelige som inhibitorer af beta-sekretase (BACE)
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern
WO2006136580A3 (en) 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
BRPI0407181A (pt) Formulação farmacêutica
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
DK1275377T3 (da) Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf
MA29492B1 (fr) Formulations stables de nanoparticules
EA200400782A1 (ru) Композиция изотретиноина с измельчением компонентов до степени наночастиц
ITMI20022549A1 (it) Composizione quaternaria comprendente come sostanza attiva la propolis.
EA201170583A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии
WO2003013441A3 (en) Levothyroxine compositions and methods

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU